Cargando…
Effect of interventional embolotherapy on FHIT and p16 expression in hepatocellular carcinoma patients
Effects of interventional embolotherapy on the expression of fragile histidine triad (FHIT) and p16 in hepatocellular carcinoma (HCC) patients were investigated. Patients with primary HCC who were definitely diagnosed and treated in the Department of Gastroenterology in Qingdao Central Hospital from...
Autores principales: | Xu, Wei, Qi, Xiaogai, Wang, Xia, Sun, Jize |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6313009/ https://www.ncbi.nlm.nih.gov/pubmed/30655841 http://dx.doi.org/10.3892/ol.2018.9648 |
Ejemplares similares
-
Recent advances in transarterial embolotherapies in the treatment of hepatocellular carcinoma
por: Lee, Edward Wolfgang, et al.
Publicado: (2017) -
Aberrant FHIT transcripts in hepatocellular carcinomas.
por: Chen, Y. J., et al.
Publicado: (1998) -
Image-Guided Embolotherapy of Arteriovenous Malformations of the Face
por: Schmidt, Vanessa F., et al.
Publicado: (2022) -
Restored expression of Fhit protein in Fhit-minus breast cancer cells
por: Campiglio, M, et al.
Publicado: (2001) -
Impaired FHIT expression characterizes serous ovarian carcinoma
por: Ozaki, K, et al.
Publicado: (2001)